Status:
COMPLETED
Safety and Feasibility Study of the Chartis System
Lead Sponsor:
Pulmonx Corporation
Conditions:
Bronchoscopy
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety and feasibility of the Chartis System in measuring air flow and pressures in isolated lung compartments during bronchoscopy.
Eligibility Criteria
Inclusion
- Scheduled to undergo clinically indicated routine diagnostic bronchoscopy
Exclusion
- Hyperexcretive chronic bronchitis or excessive sputum secretion
- Active pulmonary infection
- FEV1 \<20% predicted
- FVC \<50% predicted
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00684684
Start Date
May 1 2008
End Date
November 1 2008
Last Update
January 22 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thoraxklinik am Universitatsklinikum Heidelberg
Heidelberg, Germany, D-69126